D.P. Abhushan Ltd schedules board meeting on July 20 to approve Q2 2026 unaudited results

What D.P. Abhushan Ltd announced

D.P. Abhushan Ltd filed a board‑meeting intimation with BSE on 13 July 2026. The notice states that the Board of Directors will convene on 20 July 2026 to consider and approve the company’s unaudited financial results for the quarter ended 30 June 2026. The board may also discuss any other business that may arise.

Meeting details

• Date of meeting: 20 July 2026 (Monday)
• Venue/Mode: Not specified in the filing.
• Filing date: 13 July 2026, 06:10:16 UTC.
• Reference number: BSE filing – 544161.

The notice does not provide the time of the meeting, the location, or the method (physical or virtual). It merely outlines the primary agenda item – approval of the unaudited quarterly results – and leaves room for additional matters that the board may deem appropriate.

Agenda of the board

The filing lists two broad agenda points:

1. Consideration and approval of unaudited financial results for the quarter ended 30 June 2026. This typically involves reviewing the profit‑and‑loss statement, balance sheet, cash‑flow statement and related disclosures prepared by management.
2. Any other business that the board may decide to discuss. No further specifics are given, which is common in such statutory notices.

Key facts at a glance

Why this matters for investors

The filing signals that the company will soon disclose its financial performance for the quarter ended 30 June 2026. While the results are unaudited, they provide an early view of revenue, profitability and cash‑flow trends, which can be useful for shareholders monitoring the company’s operational health. The meeting may also address other corporate matters, but no details are disclosed, so investors should await the formal minutes or subsequent disclosures for any additional information.

Conclusion

D.P. Abhushan Ltd has formally announced a board meeting on 20 July 2026 to approve its unaudited Q2 2026 financial results. No quantitative data were shared in the notice, and the filing does not reveal any other agenda items beyond the standard approval and any ancillary business. Investors should watch for the forthcoming results and any post‑meeting communications for further insight.